Real-World Evidence on the Diagnostic and Clinical Characteristics of Asthma in Japanese Patients with COPD: The ACO Japan Cohort Study

References

• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD: 2022 report. Available from: https://goldcopd.org/wp-content/uploads/2021/12/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf. Accessed December 21, 2022.
   Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention: 2022 report. Available from: https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf. Accessed December 21, 2022.
   Google Scholar
• Suzuki M, Makita H, Konno S, et al. Asthma-like features and clinical course of chronic obstructive pulmonary disease. An analysis from the Hokkaido COPD cohort study. Am J Respir Crit Care Med. 2016;194:1358–1365. doi:10.1164/rccm.201602-0353OC
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma, Global Initiative for Chronic Obstructive Lung Disease. Diagnosis of diseases of chronic airflow limitation: asthma, COPD and asthma-COPD overlap syndrome (ACOS); 2015. Available from: https://goldcopd.org/wp-content/uploads/2016/04/GOLD_ACOS_2015.pdf. Accessed December 21, 2022.
   Google Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555. doi:10.1164/rccm.200703-456SO
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Tebboth A, Gayle A, Ternouth A, Ramscar N. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice. NPJ Prim Care Respir Med. 2017;27:43. doi:10.1038/s41533-017-0040-z
   PubMed Web of Science ®Google Scholar
• Gaspar Marques J, Lobato M, Leiria Pinto P, Neuparth N, Carreiro MP. Asthma and COPD “overlap”: a treatable trait or common several treatable-traits? Eur Ann Allergy Clin Immunol. 2020;52:148–159. doi:10.23822/EurAnnACI.1764-1489.138
   Web of Science ®Google Scholar
• Sin DD, Miravitlles M, Mannino DM, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016;48:664–673. doi:10.1183/13993003.00436-2016
   PubMed Web of Science ®Google Scholar
• Cosio BG, Soriano JB, López-Campos JL, et al. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest. 2016;149:45–52. doi:10.1378/chest.15-1055
   PubMed Web of Science ®Google Scholar
• Plaza V, Álvarez F, Calle M, et al. Consensus on the asthma-COPD overlap syndrome (ACOS) between the Spanish COPD guidelines (GesEPOC) and the Spanish guidelines on the management of asthma (GEMA). Arch Bronconeumol. 2017;53:443–449. doi:10.1016/j.arbres.2017.04.002
   PubMed Web of Science ®Google Scholar
• The Japanese Respiratory Society. The JRS Guidelines for the Management of ACO 2018. Tokyo: Medical Review; 2017.
   Google Scholar
• Hashimoto S, Sorimachi R, Jinnai T, Ichinose M. Asthma and chronic obstructive pulmonary disease overlap according to the Japanese Respiratory Society diagnostic criteria: the prospective, observational ACO Japan cohort study. Adv Ther. 2021;38:1168–1184. doi:10.1007/s12325-020-01573-x
   PubMed Web of Science ®Google Scholar
• Hashimoto S, Sorimachi R, Makita N, et al. Real-world status of medical care and treatment of chronic obstructive pulmonary disease by respiratory specialists in Japan. Adv Ther. 2022;39:4509–4521. doi:10.1007/s12325-022-02167-5
   Web of Science ®Google Scholar
• Mekov E, Nuñez A, Sin DD, et al. Update on asthma-COPD overlap (ACO): a narrative review. Int J Chron Obstruct Pulmon Dis. 2021;16:1783–1799. doi:10.2147/COPD.S312560
   PubMed Web of Science ®Google Scholar
• Jo YS, Hwang YI, Yoo KH, et al. Effect of inhaled corticosteroids on exacerbation of asthma-COPD overlap according to different diagnostic criteria. J Allergy Clin Immunol Pract. 2020;8:1625–1633. doi:10.1016/j.jaip.2020.01.004
   Web of Science ®Google Scholar
• Uchida A, Sakaue K, Inoue H. Epidemiology of asthma-chronic obstructive pulmonary disease overlap (ACO). Allergol Int. 2018;67:165–171. doi:10.1016/j.alit.2018.02.002
   Web of Science ®Google Scholar
• Abe K, Miyawaki A, Nakamura M, Ninomiya H, Kobayashi Y. Trends in hospitalizations for asthma during COVID-19 outbreak in Japan. J Allergy Clin Immunol Pract. 2021;9:494–496. doi:10.1016/j.jaip.2020.09.060
   Web of Science ®Google Scholar
• Davies GA, Alsallakh MA, Sivakumaran S, et al. Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales. Thorax. 2021;76:867–873. doi:10.1136/thoraxjnl-2020-216380
   PubMed Web of Science ®Google Scholar
• Shah SA, Quint JK, Nwaru BI, Sheikh A. Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data. Thorax. 2021;76:860–866. doi:10.1136/thoraxjnl-2020-216512
   PubMed Web of Science ®Google Scholar
• Huh K, Kim Y-E, Ji W, et al. Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study. Thorax. 2021;76:939–941. doi:10.1136/thoraxjnl-2020-216526
   PubMed Web of Science ®Google Scholar
• Lange P, Çolak Y, Ingebrigtsen TS, Vestbo J, Marott JL. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. Lancet Respir Med. 2016;4:454–462. doi:10.1016/S2213-2600(16)00098-9
   PubMed Web of Science ®Google Scholar
• Rabe KF, Martinez FJ, Ferguson GT, et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N Engl J Med. 2020;838:35–48. doi:10.1056/NEJMoa1916046
   Google Scholar
• Lipson DA, Barnhart F, Brealey N, et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med. 2018;378:1671–1680. doi:10.1056/NEJMoa1713901
   PubMed Web of Science ®Google Scholar
• Lee MC, Lee CH, Chien SC, et al. Inhaled corticosteroids increase the risk of pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study [published correction appears in Medicine (Baltimore). 2017;96:e8579]. Medicine (Baltimore). 2015;94:e1723. doi:10.1097/MD.0000000000001723
   Web of Science ®Google Scholar
• Crim C, Calverley PMA, Anderson JA, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J. 2009;34:641–647. doi:10.1183/09031936.00193908
   PubMed Web of Science ®Google Scholar
• Ichinose M, Fukushima Y, Inoue Y, et al. Efficacy and safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology in Japanese patients with COPD: a subgroup analysis of the KRONOS study. Int J Chron Obstruct Pulmon Dis. 2019;14:2979–2991. doi:10.2147/COPD.S220850
   Web of Science ®Google Scholar
• Kato M, Tomii K, Hashimoto K, et al. The IMPACT study – single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: efficacy and safety in a Japanese population. Int J Chron Obstruct Pulmon Dis. 2019;14:2849–2861. doi:10.2147/COPD.S226601
   PubMed Web of Science ®Google Scholar
• Silkoff PE, Laviolette M, Singh D, et al. Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study. Respir Res. 2016;17:43. doi:10.1186/s12931-016-0360-5
   PubMed Web of Science ®Google Scholar
• Takayama Y, Ohnishi H, Ogasawara F, Oyama K, Kubota T, Yokoyama A. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap. Int J Chron Obstruct Pulmon Dis. 2018;13:2525–2532. doi:10.2147/COPD.S167600
   PubMed Web of Science ®Google Scholar
• Ichinose M, Takahashi T, Sugiura H, et al. Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre. Eur Respir J. 2000;15:248–253. doi:10.1034/j.1399-3003.2000.15b05.x
   PubMed Web of Science ®Google Scholar
• Chipps BE, Jarjour N, Calhoun WJ, et al. A comprehensive analysis of the stability of blood eosinophil levels. Ann Am Thorac Soc. 2021;18:1978–1987. doi:10.1513/AnnalsATS.202010-1249OC
   Web of Science ®Google Scholar